pharmacotherapy

Pharmacotherapy for Methamphetamine/Amphetamine Use Disorder — A Systematic Review and Meta-Analysis

Citation
Chan, B., Freeman, M., Kondo, K., Ayers, C., Montgomery, J., Paynter, R., & Kansagara, D. (2019). Pharmacotherapy for Methamphetamine/Amphetamine Use Disorder–A Systematic Review and Meta‐analysis. Addiction.
Publication Date

This meta-analysis of research on medication to treat methamphetamine use disorder finds that only one medication, methylphenidate, has any efficacy in reducing use. 

Effectiveness Bank Analysis: Therapy ‘Toolbox’ Helps Rescue Poorly Recovering Patients at London Maintenance Clinic

Citation
Lancet Psychiatry: 2019, 6, p. 391-402.
Publication Date

Instead of a set programme, a clinic in London tried offering patients prescribed methadone or buprenorphine but still using heroin or cocaine a selection from a suite of well-supported psychological interventions tailored to the patient, and then systematically re-tailored in the light of how they responded.

Effectiveness Bank Analysis: “Game-Changer” Opiate Addiction Medication Proves Effective in US Trial

Citation
Lancet: 2019, 393, p. 778-790.
Publication Date

Medication of the type heralded as a possible “game-changer” by one of the UK’s leading addiction treatment clinicians and researchers proved its worth in a US placebo-controlled trial. Buprenorphine injections with effects lasting a month are now available in the UK, offering a new option for treating dependence on heroin and allied drugs.

Effectiveness Bank Analysis: UPDATED Long-Acting Buprenorphine an Advance on Daily Doses

Citation
JAMA Internal Medicine: 2018, 178(6), p. 764-773.
Publication Date

*Updated with UK licensing information and advice released in February 2019 by the National Institute for Health and Care Excellence*

What could prove a technical advance in the medication-based treatment of dependence on heroin and allied drugs was rigorously tested and partially vindicated among hundreds of patients at over 30 US clinics.

Webinar: Treatment and Prevention of Opioid Use Disorder: Overview

A webinar on opioid use disorder by Dr. Dennis McCarty is now available through the Addiction Technology Transfer Centre (ATTC) website. The hour long webinar took place in April 2018 and discusses treatment and prevention. The webinar format allowed viewers to download Dr McCarty's slides, make comments and then take part in a Q&A at the end of the session. Great Lakes ATTC, Northwest ATTC, and Pacific Southwest ATTC joined a team of NIDA's clinical